Analyze Diet

European journal of obstetrics, gynecology, and reproductive biology.

Periodical
Gynecology
Obstetrics
Reproductive Medicine
Reproduction
Publisher:
Excerpta Medica.. Limerick : Elsevier Scientific Publishers
Frequency: Twelve no. a year
Country: Ireland
Language: English
Author(s):
Nederlandse Vereniging voor Obstetrie en Gynaecologie., Société royale belge de gynécologie et d'obstétrique.
Start Year:1973 -
ISSN:
0301-2115 (Print)
1872-7654 (Electronic)
0301-2115 (Linking)
Impact Factor
2.6
2022
NLM ID:0375672
(DNLM):E16200000(s)
(OCoLC):02253996
Coden:EOGRAL
LCCN:sn 80001293
Classification:W1 EU72DK
Models of fetal growth restriction.
European journal of obstetrics, gynecology, and reproductive biology    September 11, 2003   Volume 110 Suppl 1 S29-S39 doi: 10.1016/s0301-2115(03)00170-2
Schröder HJ.The growth of the fetus is determined by substrate supply mostly for mass accretion and energy gain, and by control systems. Experiments with whole animal models will face the following problems: (1) The fetus, like a three compartmental "Russian doll", is at the end of a long supply chain. There are interactions (e.g. hormones) and partitioning of substrates between the compartments. (2) The fetal organism is growing and differentiating at the same time and not in a steady-state. Experimental results thus depend on gestational age. (3) About 75% of animal experiments on fetal growth restricti...
Effect of continuous and sequential oral estrogen-progestogen replacement regimens on postmenopausal bone loss: a 2-year prospective study.
European journal of obstetrics, gynecology, and reproductive biology    January 15, 2002   Volume 99, Issue 2 261-265 doi: 10.1016/s0301-2115(01)00382-7
Figueras F, Castelo-Branco C, Pons F, Sanjuán A, Vanrell JA.The aim of the present study was to determine whether assignment to continuous estrogen-progestin therapy is more effective in protecting against bone loss than assignment to a sequential regimen. Methods: A total of 104 postmenopausal women were randomly assigned to one of two groups of treatment, Conjugated Equine Estrogens and Medroxyprogestin without interruption (continuous group) and Conjugated Equine Estrogens over 25 days with Medroxyprogestin beyond the 14th day (sequential group). Bone mineral density (BMD) was measured at inclusion, 12 and 24 months later by dual energy X-ray absorp...